Rheumatoid arthritis progression mediated by activated synovial fibroblasts.

Trends Mol Med

Dept of Internal Medicine and Rheumatology, Justus-Liebig-University Gießen, Kerckhoff-Klinik, Benekestr. 2-8, D-61231 Bad Nauheim, Germany.

Published: October 2010

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial hyperplasia and progressive joint destruction. Rheumatoid arthritis synovial fibroblasts (RASFs) are leading cells in joint erosion and contribute actively to inflammation. RASFs show an activated phenotype that is independent of the inflammatory environment and requires the combination of several factors. Although new aspects regarding RASF activation via matrix degradation products, epigenetic modifications, inflammatory factors, Toll-like receptor (TLR) activation and others have recently been uncovered, the primary pathophysiological processes in early arthritis leading to permanent activation are mostly unknown. Here, we review new findings regarding RASF activation and their altered behavior that contribute to matrix destruction and inflammation as well as their potential to spread RA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2010.07.004DOI Listing

Publication Analysis

Top Keywords

rheumatoid arthritis
12
synovial fibroblasts
8
rasf activation
8
arthritis progression
4
progression mediated
4
mediated activated
4
activated synovial
4
fibroblasts rheumatoid
4
arthritis chronic
4
chronic inflammatory
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!